Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative bioavailability study of empagliflozin + metformin fixed-dose combination tablets in healthy Chinese volunteers
ChiCTR-TTRCC-14004624Phase 4Recruiting
- Sponsor
- Beijing Shijitan Hospital
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of empagliflozin and metformin in hyperglycemia (4 cohorts), sponsored by Beijing Shijitan Hospital. Primary endpoints: Relative bioavailability of empagliflozin and metformin fixed-dose combination versus coadministered single tablets, Blood pressure and 2 more. Started May 2014; status: recruiting.
02
Drugs
empagliflozinmetformin
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on ChiCTR-TTRCC-14004624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TTRCC-14004624.